Home / Telmisartan and Diuretics / Czechia
CZ ATC C09DA07 · updated 2 Nov 2026
Telmisartan and Diuretics shortage in Czechia
Is there a Telmisartan and Diuretics shortage in Czechia?
Yes. As of 2 Nov 2026, 13 Telmisartan and Diuretics products are reported short in Czechia, the first since 31 Oct 2023. The company estimate for the return is 13 Nov 2026 (latest 22 Jan 2027). Main reason: manufacturing problem.
Also short in Canada, Italy, Spain. All countries.
Affected products in Czechia
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| CZ | TELMISARTAN/HYDROCHLOROTHIAZID AUXILTO 80MG/12,5MG 80MG/12,5MG TBL NOB 28 | Zentiva, k.s., Praha | 31 Oct 2023 | not given | Manufacturing problem Výrobní důvody |
| CZ | TELMISARTAN/HYDROCHLOROTHIAZID AUXILTO 80MG/12,5MG 80MG/12,5MG TBL NOB 56 | Zentiva, k.s., Praha | 31 Oct 2023 | not given | Manufacturing problem Výrobní důvody |
| CZ | TELMISARTAN/HYDROCHLOROTHIAZID AUXILTO 80MG/12,5MG 80MG/12,5MG TBL NOB 100 | Zentiva, k.s., Praha | 31 Dec 2023 | not given | Manufacturing problem Výrobní důvody |
| CZ | TELMISARTAN/HYDROCHLOROTHIAZID AUXILTO 80MG/25MG 80MG/25MG TBL NOB 100 | Zentiva, k.s., Praha | 31 Dec 2023 | not given | Manufacturing problem Výrobní důvody |
| CZ | TELMISARTAN/HYDROCHLOROTHIAZID AUXILTO 80MG/25MG 80MG/25MG TBL NOB 28 | Zentiva, k.s., Praha | 31 Dec 2023 | not given | Manufacturing problem Výrobní důvody |
| CZ | TELMISARTAN/HYDROCHLOROTHIAZID AUXILTO 80MG/25MG 80MG/25MG TBL NOB 56 | Zentiva, k.s., Praha | 31 Dec 2023 | not given | Manufacturing problem Výrobní důvody |
| CZ | YLPIO 80MG/2,5MG 80MG/2,5MG TBL NOB 100 | PRO.MED.CS Praha a.s. | 4 Jun 2025 | 31 Dec 2026 | Manufacturing problem Výrobní důvody |
| CZ | TEZEO HCT 40MG/12,5MG 40MG/12,5MG TBL NOB 30 | Zentiva, k.s., Praha | 21 Sep 2026 | 13 Nov 2026 | Manufacturing problem Výrobní důvody |
| CZ | TELMISARTAN/HYDROCHLOROTHIAZID TEVA 80MG/12,5MG 80MG/12,5MG TBL NOB 28 I | Teva Pharmaceuticals CR, s.r.o., Praha | 12 Oct 2026 | 31 Dec 2026 | Commercial decision or withdrawal Obchodní/marketingové důvody |
| CZ | TEZEO HCT 80MG/12,5MG 80MG/12,5MG TBL NOB 30 | Zentiva, k.s., Praha | 15 Oct 2026 | 27 Nov 2026 | Manufacturing problem Výrobní důvody |
| CZ | TELMISARTAN/HYDROCHLOROTHIAZID SANDOZ 80MG/12,5MG 80MG/12,5MG TBL FLM 100 | Sandoz s.r.o., Praha | 19 Oct 2026 | 15 Jan 2027 | Manufacturing problem Výrobní důvody |
| CZ | TELMISARTAN/HYDROCHLOROTHIAZID SANDOZ 80MG/12,5MG 80MG/12,5MG TBL FLM 30 | Sandoz s.r.o., Praha | 30 Oct 2026 | 22 Jan 2027 | Manufacturing problem Výrobní důvody |
| CZ | TELMISARTAN/HYDROCHLOROTHIAZID SANDOZ 80MG/25MG 80MG/25MG TBL FLM 30 anticipated | Sandoz s.r.o., Praha | 3 Nov 2026 | 15 Jan 2027 | Manufacturing problem Výrobní důvody |
Source
SÚKL (State Institute for Drug Control), market reports. Official list. Products whose latest market report is a supply interruption; one row per SÚKL code.